real world evidence

Real-world evidence and qualitative research: the ELICIT podcast

In the first episode of the ELICIT podcast, a new series produced in partnership with Cerner Enviza, the speakers discuss qualitative real-world evidence and a unique dementia project from Singapore. First, they look at why qualitative real-world evidence is important to pharma, what the criteria is for good qualitative research and why stakeholder preference studies …

Real-world evidence and qualitative research: the ELICIT podcast Read More »

Janssen on driving R&D innovation with data science

The amount of patient data has skyrocketed, providing opportunities to gain a deeper understanding of diseases that are particularly complex or areas with a high level of unmet need, according to Janssen’s Najat Khan. She discussed the implications of this direction of travel for pharma, and some of the changes she’s seen in data science …

Janssen on driving R&D innovation with data science Read More »

AI meets RWE: The future of drug assessment?

Savana’s Dr Ignacio Medrano explains how machine learning and natural language processing technology is opening up huge amounts of previously-inaccessible real-world evidence (RWE) for pharma and regulators. This article appears in out digital magazine Deep Dive: Market Access 2021. Read below for a preview: Real world evidence (RWE) is rapidly evolving. Having gone from being …

AI meets RWE: The future of drug assessment? Read More »

The rise of real-world evidence: unlocking the potential in EHRs

The COVID-19 pandemic has demonstrated the importance of health data and how its availability in real time can reveal new insights and innovations that can improve health outcomes for patients. International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health …

The rise of real-world evidence: unlocking the potential in EHRs Read More »

The rise of real-world evidence: unlocking the potential in EHRs

The COVID-19 pandemic has demonstrated the importance of health data and how its availability in real time can reveal new insights and innovations that can improve health outcomes for patients. International deep real-world evidence company Savana is on a mission to give health researchers the power to unlock the clinical value embedded within electronic health …

The rise of real-world evidence: unlocking the potential in EHRs Read More »

AI, big data and deep real-world evidence – the challenges and opportunities

Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes. An important source of RWE has, until recently, been locked in the electronic health record (EHR). Now, artificial intelligence …

AI, big data and deep real-world evidence – the challenges and opportunities Read More »

Medable, Seqster pair up on real-world data for remote trials

With COVID-19 forcing a shift towards decentralised trials, two digital health firms – Medable and Seqster – have teamed up to offer ways to also incorporate real-world data into remote study designs.  Decentralised studies reduce or eliminate the need to travel to clinical sites, and the two partners want to go even further by harnessing …

Medable, Seqster pair up on real-world data for remote trials Read More »

Unlocking health data to improve oncology outcomes

As the largest single-payer healthcare system in Europe, the UK’s National Health Service (NHS) has a uniquely beneficial health data and real-world evidence (RWE) environment. It’s one that has global potential to improve patient outcomes but efforts to harness the true potential of these information flows are only just beginning. The foundation for this is …

Unlocking health data to improve oncology outcomes Read More »

Real-world evidence: breaking boundaries in rare disease

The COVID-19 pandemic has added a new layer of complexity to the drug development process. Launch timelines have been delayed and clinical trials have been postponed or suspended. As a result, life sciences companies are turning to novel methods of collecting clinical data and innovative trial design. The generation of data to show the significant …

Real-world evidence: breaking boundaries in rare disease Read More »

Harnessing The Power of Real World Evidence to Fight COVID-19 Pandemic

With the ongoing pandemic of COVID-19, there is long wait for the vaccine to be approved. Even after the vaccine gets approved, there is no assurance of the complete eradication of virus. There will still be percentage of people who contract the illness. Therefore, it is very important to trace and detect the treatments in …

Harnessing The Power of Real World Evidence to Fight COVID-19 Pandemic Read More »

How real human experiences can power a healthier future

As part of our series of opinion pieces from leaders at Janssen, the company’s Maria Raad looks at how we can embrace tech and data science to overcome increasing pressures on healthcare systems. For the next generation born in the western world, living to be the age of 100 will be the norm. While this …

How real human experiences can power a healthier future Read More »

Aetion completes $82M Series B round with $19M extension

The healthcare analytics company said it had raised the extension funding from three new investors and would use it to accelerate development of its real-world evidence technology.

Roche, PicnicHealth start RWD partnership with multiple sclerosis focus

The companies will use a combination of more than seven years of medical record data with five years of prospective data on 5,000 MS patients, including real-world outcomes data and MRI images. Other disease areas to be explored include hematology and rare diseases.

5 Ways RWE is Fueling the Fight Against COVID-19

As we discussed in an earlier blog post, real-world evidence can bring value to every stage of the drug life cycle, from early discovery to post-market. Now, as the worldwide research community continues to battle the COVID-19 pandemic, we are also discovering how real-world data and real-world evidence have something to offer in these efforts …

5 Ways RWE is Fueling the Fight Against COVID-19 Read More »

How Are Regulatory Agencies Reacting to the Use of Real-World Evidence?

As we have discussed here previously, real-world data (RWD) and real-world evidence (RWE) offer many potential benefits in every stage of the drug discovery and development process, continuing on into post-market surveillance. With drug developers and other researchers becoming more interested in using RWD and the RWE that results from analyzing it, regulatory agencies have …

How Are Regulatory Agencies Reacting to the Use of Real-World Evidence? Read More »